← Evidence map

TrialGut1997

Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.

J Bauditz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

1997

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

this paperpooled ittrialcites it

Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease. | OpenQuestion